New York, Jan 26 US-based drugmaker Moderna on Monday said its Covid-19 vaccine retains neutralising activity against emerging variants first identified in the UK and South Africa. Vaccination with the Moderna Covid-19 Vaccine produced neutralising titers against all key emerging
Dhaka, Jan 20 Bangladesh Health Minister Zahid Maleque has said that the country would receive two million doses of the AstraZeneca Covid-19 vaccine (Covishield) from India as a “gift” on Wednesday. Maleque confirmed to IANS that a special Air India
New Delhi, Jan 6 A dry run for the Covid vaccine will be conducted at 8 sites in the national capital on Wednesday, officials said. The dry run will be held at two hospitals under the North Delhi Municipal Corporation
Geneva, Jan 6 The World Health Organisation (WHO) on Tuesday said that Covid-19 patients should be given two doses of the Pfizer/BioNTech vaccine within a period of 21-28 days. Alejandro Cravioto, chairman of WHO’s Strategic Advisory Group of Experts on
New Delhi, Dec 29 Pune-based Serum Institute of India on Monday expressed hope at the possibility of Covid-19 vaccine – Covishield receiving the regulatory approval in “few days”, while emphasising that the company has a massive stockpile 40-50 million doses.
New Delhi, Dec 21 Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest,
New Delhi, Dec 20 Union Health Minister Harsh Vardhan on Saturday announced that India is at the cusp of authorizing the first set of Covid-19 vaccines and expressed the need for an expeditious vaccination drive to cover all the target
New Delhi, Dec 19 India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, said in an interview with Rossiya 24 TV channel. “In
Moscow, Dec 18 India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with a TV channel. “In India,
New Delhi, Dec 8 (IANS) Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by
Chandigarh, Dec 2 With the Covid-19 vaccine in the final stages of operationalisation in India, Chief Minister Amarinder Singh on Wednesday said he will take the first shot of the vaccine in Punjab, once it is cleared by the Indian
Chennai, Dec 1 Vaccine development company Serum Institute, India on Tuesday said the Covidshield vaccine will not be released for mass use unless it is proven immunogenic, and safe. The company also said the serious adverse event (SAE) that happened
Moscow, Nov 24 Russia’s Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of Phase 3 clinical trial data, its developers said on Tuesday. The analysis was based
New York, Nov 20 Pfizer announced Friday it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent efficacy in a totality of two data sets released in the last 10 days. The chief
New York, Nov 20 Pfizer on Friday announced that it is moving ahead with its request of asking the US regulators to allow emergency use of its Covid-19 vaccine, which has shown 95 per cent efficacy in a totality of
New Delhi, Oct 29 Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines. Sanofi and GSK intend
Moscow, Oct 15 Russian President Vladimir Putin on Wednesday announced that the country has registered the second Covid-19 vaccine, according to media reports. Russia became the first country to give regulatory approval to a Covid-19 vaccine in August when Sputnik
New York, Sep 19 US-based biotech firm Moderna is actively preparing for a potential commercial launch of mRNA-1273, its Covid-19 vaccine, the company’s CEO has said. The announcement comes amid an unprecedented race worldwide to bring a vaccine to protect
New York, Sep 9 With the upcoming US presidential elections heating up the vaccine race, nine biopharma leaders on Tuesday signed a historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in the
United Nations, Sep 8 In what could possibly be the world’s largest and fastest ever procurement and supply of vaccines, the United Nations Children’s Fund (Unicef) has said that it will lead efforts for Covid-19 vaccine supply for 92 low
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
 |
 |
 |
